Osteoprotegerin (OPG) Pathways in Bone Diseases and Its Application in Therapeutic Perspectives

Biointerface Research in Applied Chemistry - Romania
doi 10.33263/briac102.193200
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

AMG Transcend Association

Related search

Role of Osteoprotegerin (OPG) in Cancer

Clinical Science
Medicine
2006English

Role of Sclerostin in Bone and Cartilage and Its Potential as a Therapeutic Target in Bone Diseases

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2013English

RANKL/RANK/OPG System Beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Osteoprotegerin Ligand and Osteoprotegerin: Novel Implications for Osteoclast Biology and Bone Metabolism

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Functions of RANKL/RANK/OPG in Bone Modeling and Remodeling

Archives of Biochemistry and Biophysics
BiochemistryMolecular BiologyBiophysics
2008English

Nitric Oxide-Mediated Pathways and Its Role in the Degenerative Diseases

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases

Advances in Protein Chemistry and Structural Biology
BiochemistryStructural Biology
2017English

Osteoprotegerin in Bone Metastases: Mathematical Solution to the Puzzle

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy